Qihe Biotech
About:
Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
Top Investors: Gaorong Capital, Source Code Capital, CD Capital, Xinshang Capital, Apricot Capital
Description:
Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
Total Funding Amount:
200M CNY
Headquarters Location:
Suzhou, Jiangsu, China
Founded Date:
2021-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2023-04-20
IPO Status:
Private
Industries:
© 2025 bioDAO.ai